Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 6, 2002, Pages 1167-1170

  Benedetti, Francesco ^a   Lucca, Adelio ^a   Brambilla, Francesca ^a   Colombo, Cristina ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant response; Bipolar disorder; Interleukine 6; Sleep deprivation

Indexed keywords

AMITRIPTYLINE; INTERLEUKIN 6; LITHIUM;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; HUMAN; MAJOR DEPRESSION; MOOD; PREDICTION; PROTEIN BLOOD LEVEL; SLEEP; SLEEP DEPRIVATION; SLEEP PHASE ADVANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; SLEEP DEPRIVATION; SLEEP STAGES;

EID: 0036774353     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00255-5     Document Type: Article

References (35)

1. Aitken R.C.B. Measurement of feelings using Visual Analogy Scale. Proc. R. Soc. Med. 62:1969;989-993.
2. American Psychiatric Association Diagnostic and Statistic Manual of Mental Disorders. 4th ed. 1994;APA Press, Washington, DC.
3. Benedetti F., Barbini B., Campori E., Colombo C., Smeraldi E. Ongoing lithium treatment prevents relapse after sleep deprivation. J. Clin. Psychopharmacol. 19:1999;240-245.
4. Benedetti F., Serretti A., Colombo C., Campori E., Barbini B., Di Bella D., Smeraldi E. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatry. 156:1999;1450-1452.
5. Benedetti F., Barbini B., Campori E., Cigala Fulgosi M., Pontiggia A., Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings sustaining the internal coincidence model? J. Psychiatr. Res. 35:2001;323-329.
6. Berger M., Vollmann J., Hohagen F., König A., Lohner H., Voderholzer U., Riemann D. Sleep deprivation combined with consecutive sleep phase advance as a fast acting therapy in depression: an open pilot trail in medicated and unmedicated patients. Am. J. Psychiatry. 154:1997;870-872.
7. Colombo C., Lucca A., Benedetti F., Barbini B., Campori E., Smeraldi E. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatr. Res. 95:2000;43-53.
8. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247:1997;228-233.
9. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
10. Kubera M., Kenis G., Bosmans E., Zieba A., Dudek D., Nowak G., Maes M. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol. J. Pharmacol. 52:2000;237-241.
11. Kubera M., Simbirtsev A., Mathison R., Maes M. Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Psychiatr. Res. 96:2000;255-266.
12. Kubera M., Holan V., Mathison R., Maes M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology. 25:2000;785-797.
13. Kuhs H., Farber D., Borgstadt S., Mrosek S., Tolle R. Amitriptyline in combination with repeated late sleep deprivation versus amitriptyline alone in major depression. A randomised study. J. Affect. Disord. 37:1996;31-41.
14. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 22:2000;370-379.
15. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol. Behav. 47:1990;957-961.
16. Leu S.J., Shiah I.S., Yatham L.N., Cheu Y.M., Lam R.W. Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy. J. Affect. Disord. 63:2001;27-34.
17. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology. 40:1999;171-176.
18. Lin A., Song C., Kenis G., Bosmans E., De Jongh R., Scharpe S., Maes M. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J. Affect. Disord. 58:2000;69-74.
19. Maes M., Scharpè S., Meltzer H.Y., Bosmans E., Suy E., Calabrese J., Cosyns P. Relationships between interleukin-6 activity, acute phase proteins and hypothalamic-pituitary-adrenal axis function in severe depression. Psychiatr. Res. 49:1993;11-27.
20. Maes M., Meltzer H.Y., Bosmans E., Bergams R., Vandoolaeghe E., Ranjan R., Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34:1995;301-309.
21. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J. Psychiatr. Res. 29:1995;141-152.
22. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 9:1997;853-858.
23. Maes M., Song C., Lin A.H., Pioli R., Kenis G., Kubera M., Bosmans E. In vitro immunoregulatory effects of lithium in healthy volunteers. Psychopharmacology. 143:1999;401-407.
24. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol. Psychiatry. 45:1999;833-839.
25. Maes M., Bocchio Chiavetto L., Bignotti S., Battisa Tura G., Pioli R., Boin F., Kenis G., Bosmans E., De Jongh R., Lin A., Racagni G., Altamura C.A. Effect of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur. Neuropsychopharmacol. 10:2000;119-124.
26. Riemann D., Konig A., Hohagen F., Kiemen A., Voderholzer U., Backhaus J., Bunz J., Wesiack B., Hermle L., Berger M. How to preserve the antidepressive effect of sleep deprivation: a comparison of sleep phase advance and sleep phase delay. Eur. Arch. Psychiatry Clin. Neurosci. 249:1999;231-237.
27. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 41:1995;534-538.
28. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. NY Acad. Sci. 762:1995;474-476.
29. Sluzewska A., Rybakowski J.K., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatr. Res. 64:1996;161-167.
30. Sluzewska A., Sobieska M., Rybakowski J.K. Changes in acute-phase proteins during lithium potentiation of antidepressant in refractory depression. Neuropsychobiology. 35:1997;123-127.
31. Smeraldi E., Benedetti F., Barbini B., Campori C., Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression: a placebo-controlled trial. Neuropsychopharmacology. 20:1999;380-385.
32. Song C., Lin A., Bonaccorso S., Heide C., Verkerk R., Kenis G., Bosmans E., Scharpe S., Whelan A., Cosyns P., Jongh R.D., Maes M. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J. Affect. Disord. 49:1998;211-219.
33. Thiele B., Brink I., Ploch M. Modulation of cytokine expression by hypericum extract. J. Geriatr. Psychiatry Neurol. 7(Suppl. 1):1994;S60-S62.
34. Xia Z., DePierre J.W., Nassberger L. Tricyclic antidepressant inhibit IL-6, IL-1 beta and TNF-alpha release in Human blood monocytes and interferon-gamma in T cells. Immunopharmacology. 34:1996;27-37.
35. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to psychological stressors elevates plasma interleukin-6: relationships to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 133:1993;2523-2530.